Treatment of experimental osteomyelitis by liposomal antibiotics

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 6, 2004, Pages 1103-1108

  Kadry, Ashraf A ^a   Al Suwayeh, Saleh A ^a   Abd Allah, Adel R A ^b   Bayomi, Mohsen A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Ciprofloxacin; Liposomes; S. aureus; Vancomycin

Indexed keywords

ANION; ANTIBIOTIC AGENT; CATION; CIPROFLOXACIN; CREATININE; LIPOSOME; UREA; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; ARTICLE; BONE TISSUE; CHRONIC OSTEOMYELITIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; ENCAPSULATION; EXPERIMENTAL INFECTION; IN VITRO STUDY; KIDNEY DYSFUNCTION; NEPHROTOXICITY; NONHUMAN; RABBIT; STAPHYLOCOCCUS INFECTION; TISSUE CULTURE; ULTRASOUND; UREA BLOOD LEVEL;

ANIMALS; ANTI-BACTERIAL AGENTS; CHRONIC DISEASE; CIPROFLOXACIN; DRUG CARRIERS; DRUG THERAPY, COMBINATION; HUMANS; LIPOSOMES; MICROBIAL SENSITIVITY TESTS; OSTEOMYELITIS; RABBITS; SONICATION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME; VANCOMYCIN;

EID: 12344259655     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh465     Document Type: Article

References (29)

1. Spagnolo, N., Greco, F., Rossi, A. et al. (1993). Chronic staphylococcal osteomyelitis: a new experimental rat model. Infection and Immunity 61, 5225-30.
2. Power, M. E., Olson, M. E., Domingue, P. A. et al. (1990). A rat model of S. aureus chronic osteomyelitis that provides a suitable system for studying the human infection. Journal of Medical Microbiology 33, 189-98.
3. Hienz, S. A., Sakamoto, H., Flock, J. I. et al. (1995). Development and characterization of a new model of hematogenous osteomyelitis in the rat. Journal of Infectious Diseases 171, 1230-6.
4. Mayberry-Carson, K. J., Tober-Meyer, B., Smith, J. K. et al. (1984). Bacterial adherence and glycocalyx formation in osteomyelitis experimentally induced with S. aureus. Infection and Immunity 43, 825-33.
5. Fresta, M., Spadaro, A., Cerniglia, G. et al. (1995). Intracellular accumulation of ofloxacin-loaded liposomes in human synovial fibroblasts. Antimicrobial Agents and Chemotherapy 39 1372-5.
6. Widmer, A. F. (2001). New developments in diagnosis and treatment of infection in orthopedic implants. Clinical Infectious Diseases 33, S94-106.
7. Norden, C. W. & Kennedy, E. (1971). Experimental osteomyelitis. II. Therapeutic trials and measurement of antibiotic levels in bone. Journal of Infectious Diseases 124, 565-71.
8. Norden, C. W. & Kennedy, E. (1970). Experimental osteomyelitis. I. A description of the model. Journal of Infectious Diseases 122, 410-8.
9. Berestein, G. L. (1987). Liposomes as carriers of antimicrobial agents. Antimicrobial Agents and Chemotherapy 31 675-8.
10. Furneri, P. M., Fresta, M., Puglisi, G. et al. (2000). Ofloxacin-loaded liposomes: in vitro activity and drug accumulation in bacteria. Antimicrobial Agents and Chemotherapy 44, 2458-64.
11. Fielding, F. M. (1991). Liposomal drug delivery: advantages and limitations from a clinical pharmacokinetics and therapeutic perspective. Clinical Pharmacokinetics 21, 155-64.
12. Schiffelers, R., Storm, G. & Woudenberg, I. B. (2001). Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies. Journal of Antimicrobial Chemotherapy 48, 333-44.
13. Ravaoarinoro, M., Toma, E., Agbaba, O. et al. (1993). Efficient entrapment of amikacin and teicoplanin in liposomes. Journal of Drug Targeting 1, 191-5.
14. Morgan, J. R. & Williams, K. E. (1980). Preparation and properties of iposome-associated gentamicin. Antimicrobial Agents and Chemotherapy 17, 544-8.
15. Omri, A., Ravaoarinoro, M. & Poisson, M. (1995). Incorporation, release and in vitro antibacterial activity of liposomal aminoglycosides against P. aeruginosa. Journal of Antimicrobial Chemotherapy 36, 631-9.
16. Illero, J. C., Gonzalez, G. A., Silvan, G. et al. (2000). The effects of different anaesthetic treatments on the adreno-cortical functions and glucose levels in NZW rabbits. Journal of Physiology and Biochemistry 56, 329-36.
17. Norden, C. W., Shinner, E. & Niederriter, K. (1986). Clindamycin treatment of experimental chronic osteomyelitis due to S. aureus. Journal of infectious Diseases 153, 956-9.
18. Norden, C. W. & Keleti, E. (1980). Treatment of experimental staphylococcal osteomyelitis with rifampin and trimethoprim, alone and in combination. Antimicrobial Agents and Chemotherapy 17, 591-4.
19. Norden, C. W. & Shinners, E. (1985). Ciprofloxacin as therapy for experimental osteomyelitis caused by Pseudomonas aeruginosa. Journal of Infectious Diseases 151, 291-4.
20. Norden, C. W. (1983). Experimental chronic staphylococcall osteomyelitis in rabbits: treatment with rifampin alone and in combination with other antimicrobial agents. Review of Infectious Diseases 5, Suppl. 3, S491-4.
21. Norden, C. W. & Shaffer, M. (1983). Treatment of experimental chronic osteomyelitis due to S. aureus with vancomycin and rifampin. Journal of Infectious Diseases 147, 352-7.
22. Norden, C. W. (1975). Experimental osteomyelitis. IV. Therapeutic trials with rifampin alone and in combination with gentamicin, sisomicin, and cephalothin. Journal of Infectious Diseases 132, 493-9.
23. Norden, C. W. & Budinsky, A. (1990). Treatment of experimental chronic osteomyelitis due to Staphylococcus aureus with ampicillin/sulbactam. Journal of Infectious Diseases 161 52-3.
24. Moghimi, S. M., Porter, C. J. H., Illum, L. et al. (1991). The effect of poloxamer-407 on liposome stability and targeting to bone marrow: comparison with polystyrene microspheres. International Journal of Pharmaceutics 68, 121-6.
25. Trafny, E. A., Stepinska, M., Antos, M. et al. (1995). Effects of free and liposome-encapsulated antibiotics on adherence of Pseudomonas aeruginosa to collagen type I. Antimicrobial Agents and Chemotherapy 39, 2645-9.
26. Tyrrell, D. A., Heath, T. D., Colley, C. M. et al. (1976). New aspects of liposomes. Biochimica et Biophysica Acta 457, 259-302.
27. Norden, C. W. & Keleti, E. (1980). Experimental osteomyelitis caused by Pseudomonas aeruginosa. Journal of Infectious Diseases 141, 71-5.
28. Sprandel, K. A. & Rodvold, K. A. (2003). Safety and tolerability of fluoroquinolones. Clinical Cornerstone 5, Suppl. 3, S29-36.
29. Nishino, Y., Takemura, S., Minamiyama, Y. et al. (2002). Inhibition of vancomycin-induced nephrotoxicity by targeting superoxide dismutase to renal proximal tubule cells in the rat. Redox Report 7, 317-9.